Canada has signed a deal with Cambridge-based AstraZeneca to buy up to 20 million doses of its COVID-19 vaccine candidate, Prime Minister Justin Trudeau told reporters on Friday. The medication is among the leading candidates in the global race for a vaccine, now in late-stage trials in Britain, South Africa and elsewhere.
Novo Nordisk contracts Aspen to produce insulin for Africa | Reuters Novo Nordisk (NOVOb.CO) has contracted...
Germany on Monday launched its autumn vaccination campaign to prevent respiratory infection, promoting an updated COVID-19...
Wendy Nelson stands at Uhuru Peak of Mt. Kilimanjaro, the highest point on the continent of...
Wendy Nelson watched her mother slowly die of Alzheimer’s disease, unable to move or swallow at...
Why Europe’s drug shortages may get worse | Reuter Most European countries reporting shortages of antibiotics...
